Skip to main content
Erschienen in: Clinical Rheumatology 12/2021

29.06.2021 | Brief Report

Limited added value of whole spine MRI in spondyloarthritis for disease activity assessment

verfasst von: Ummugulsum Gazel, Gizem Ayan, Dilek Solmaz, Sibel Bakirci, Jacob Karsh, Marcos Sampaio, Zaid Jibri, Sibel Zehra Aydin

Erschienen in: Clinical Rheumatology | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the added value of whole spine magnetic resonance imaging (MRI) for disease activity assessment in ankylosing spondylitis (AS) and psoriatic arthritis (PsA).

Method

Spine and sacroiliac joint (SIJ) MRI scans requested by rheumatologists between 2012 and 2018 were screened retrospectively, and patients who had known diagnosis of AS or PsA were included, if the MRI was done for disease activity assessment. All MRI scans were reviewed by two experienced musculoskeletal radiologists independently, blinded to patients’ diagnosis and to the other MRI. Comparisons were done for the presence of active and structural lesions. In addition, radiologists were asked to rate for “confidence level for active inflammation related to SpA.” Analysis was done using the consensus scores.

Results

Ninety patients with known diagnosis of AS (n = 55) or PsA (n = 35) were included. The frequency of active and structural lesions was not significantly different both in AS vs PsA, neither in the cervical/thoracic/lumbar spine or the SIJ. The percentage of people only with any inflammatory changes on the spine MRI without any inflammation in the SIJ MRI was 24% in AS and 23% in PsA. However, considering the confidence level of the radiologists on active inflammation, only one patient’s spine MRI was scored as active, while SIJ MRI being negative for inflammation.

Conclusions

The spinal MRI had limited added value to the SIJ MRI in SpA, when performed to assess disease activity, limiting its value in routine practice unless clinically indicated.
Key Points
Spine MRI adds limited value to SIJs in SpA, when performed for disease activity assessment.
SpA disease activity assessment may be restricted to sacroiliac joint MRI, unless clinically indicated.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377:2127–2137CrossRef Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377:2127–2137CrossRef
2.
Zurück zum Zitat Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT (1993) Differences in the expression of spondyloarthropathy: A comparison between ankylosing spondylitis and psoriatic arthritis. Clin Invest Med 16:1–7PubMed Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT (1993) Differences in the expression of spondyloarthropathy: A comparison between ankylosing spondylitis and psoriatic arthritis. Clin Invest Med 16:1–7PubMed
3.
Zurück zum Zitat Gladman DD (2006) Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases? Ann Rheum Dis 65(Suppl 3):iii22–iii24PubMedPubMedCentral Gladman DD (2006) Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases? Ann Rheum Dis 65(Suppl 3):iii22–iii24PubMedPubMedCentral
4.
Zurück zum Zitat Jadon DR, Sengupta R, Nightingale A, Lindsay M, Korendowych E, Robinson G et al (2017) Axial disease in psoriatic arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis 76:701–707CrossRef Jadon DR, Sengupta R, Nightingale A, Lindsay M, Korendowych E, Robinson G et al (2017) Axial disease in psoriatic arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis 76:701–707CrossRef
5.
Zurück zum Zitat Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J (2008) Mri in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 67:1276–1281CrossRef Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J (2008) Mri in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 67:1276–1281CrossRef
6.
Zurück zum Zitat Braun J, Landewe R, Hermann KG, Han J, Yan S, Williamson P et al (2006) Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 54:1646–1652CrossRef Braun J, Landewe R, Hermann KG, Han J, Yan S, Williamson P et al (2006) Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 54:1646–1652CrossRef
7.
Zurück zum Zitat Hermann KG, Baraliakos X, van der Heijde DM, Jurik AG, Landewe R, Marzo-Ortega H et al (2012) Descriptions of spinal mri lesions and definition of a positive mri of the spine in axial spondyloarthritis: a consensual approach by the asas/omeract mri study group. Ann Rheum Dis 71:1278–1288CrossRef Hermann KG, Baraliakos X, van der Heijde DM, Jurik AG, Landewe R, Marzo-Ortega H et al (2012) Descriptions of spinal mri lesions and definition of a positive mri of the spine in axial spondyloarthritis: a consensual approach by the asas/omeract mri study group. Ann Rheum Dis 71:1278–1288CrossRef
8.
Zurück zum Zitat Azmat O, Lambert RG, Jibri Z, Maksymowych WP (2017) Subchondral bone sclerosis on computed tomography – does it have any value in the diagnosis of inflammatory sacroiliitis or is it a non-specific finding? Ann Rheum Dis 76:668 Azmat O, Lambert RG, Jibri Z, Maksymowych WP (2017) Subchondral bone sclerosis on computed tomography – does it have any value in the diagnosis of inflammatory sacroiliitis or is it a non-specific finding? Ann Rheum Dis 76:668
9.
Zurück zum Zitat Lambert RG, Bakker PA, van der Heijde D, Weber U, Rudwaleit M, Hermann KG et al (2016) Defining active sacroiliitis on mri for classification of axial spondyloarthritis: update by the asas mri working group. Ann Rheum Dis 75:1958–1963CrossRef Lambert RG, Bakker PA, van der Heijde D, Weber U, Rudwaleit M, Hermann KG et al (2016) Defining active sacroiliitis on mri for classification of axial spondyloarthritis: update by the asas mri working group. Ann Rheum Dis 75:1958–1963CrossRef
10.
Zurück zum Zitat Salvarani C, Macchioni P, Cremonesi T, Mantovani W, Battistel B, Rossi F et al (1992) The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann Rheum Dis 51:73–77CrossRef Salvarani C, Macchioni P, Cremonesi T, Mantovani W, Battistel B, Rossi F et al (1992) The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann Rheum Dis 51:73–77CrossRef
11.
Zurück zum Zitat Queiro R, Sarasqueta C, Torre JC, Tinture T, Lopez-Lagunas I (2002) Prevalence and predictors of cervical involvement in psoriatic spondyloarthropathy. J Clin Rheumatol 8:23–29CrossRef Queiro R, Sarasqueta C, Torre JC, Tinture T, Lopez-Lagunas I (2002) Prevalence and predictors of cervical involvement in psoriatic spondyloarthropathy. J Clin Rheumatol 8:23–29CrossRef
12.
Zurück zum Zitat Arslan Alhussain F, Kasapoglu Gunal E, Kurum E, Bakirci S, Ozturk AB, McGonagle D et al (2019) Greater magnitude of entheseal microdamage and repair in psoriatic arthritis compared with ankylosing spondylitis on ultrasound. Rheumatology (Oxford) 58:299–303 Arslan Alhussain F, Kasapoglu Gunal E, Kurum E, Bakirci S, Ozturk AB, McGonagle D et al (2019) Greater magnitude of entheseal microdamage and repair in psoriatic arthritis compared with ankylosing spondylitis on ultrasound. Rheumatology (Oxford) 58:299–303
13.
Zurück zum Zitat Solmaz D, Bakirci S, Jibri Z, Sampaio M, Karsh J, Aydin SZ (2020) Psoriasis is an independent risk factor for entheseal damage in axial spondyloarthritis. Semin Arthritis Rheum 50:42–47CrossRef Solmaz D, Bakirci S, Jibri Z, Sampaio M, Karsh J, Aydin SZ (2020) Psoriasis is an independent risk factor for entheseal damage in axial spondyloarthritis. Semin Arthritis Rheum 50:42–47CrossRef
14.
Zurück zum Zitat Turkiewicz AM, Moreland LW (2007) Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options. Arthritis Rheum 56:1051–1066CrossRef Turkiewicz AM, Moreland LW (2007) Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options. Arthritis Rheum 56:1051–1066CrossRef
15.
Zurück zum Zitat Jadon DR, Nightingale AL, McHugh NJ, Lindsay MA, Korendowych E, Sengupta R (2015) Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy. J Rheumatol 42:21–30CrossRef Jadon DR, Nightingale AL, McHugh NJ, Lindsay MA, Korendowych E, Sengupta R (2015) Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy. J Rheumatol 42:21–30CrossRef
Metadaten
Titel
Limited added value of whole spine MRI in spondyloarthritis for disease activity assessment
verfasst von
Ummugulsum Gazel
Gizem Ayan
Dilek Solmaz
Sibel Bakirci
Jacob Karsh
Marcos Sampaio
Zaid Jibri
Sibel Zehra Aydin
Publikationsdatum
29.06.2021
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 12/2021
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-021-05837-x

Weitere Artikel der Ausgabe 12/2021

Clinical Rheumatology 12/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.